
Understanding sub-national payer expectations is critical for securing market access. Companies that align evidence generation with regional decision-making can reduce delays and optimise launch outcomes. Here’s how to approach it strategically.
Welcome to my Insights Hub. The pharmaceutical industry is constantly evolving, with new policies, technologies and market dynamics reshaping the landscape. Here, I share articles, analyses, and commentary that provide more than just the headlines—I explore what these changes mean for strategy, decision-making, and the future of the industry.
This space is an extension of my consultancy: a place to exchange ideas, challenge assumptions, and offer perspectives that help organisations stay ahead in a fast-moving sector.

Understanding sub-national payer expectations is critical for securing market access. Companies that align evidence generation with regional decision-making can reduce delays and optimise launch outcomes. Here’s how to approach it strategically.

A successful launch isn’t just about hitting milestones—it’s about anticipating market and regulatory dynamics, aligning internal stakeholders, and making real-time decisions that maximise uptake. Here are three principles I’ve found consistently effective.

Pharmaceutical strategy is evolving faster than ever. Companies that integrate digital insights, payer expectations, and patient-centric models into their commercial planning will have a competitive edge. Here’s my perspective on where the industry is heading